drugset / Trial / NCT07046273
Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a multicenter, randomized, open, parallel-controlled, Phase III clinical study aimed to evaluate the efficacy and safety of semaglutide injection and Ozempic® in patients with type 2 diabetes.
Timeline
- Start
- 2025-08-01
- Primary completion
- 2028-08-01
- Completion
- 2029-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | F027 | Unknown | 1 mg | — |
| Comparator | Semaglutide | Peptide | 1 mg | — |